Needham analyst Mayank Tandon lowered the firm’s price target on Alkami (ALKT) to $32 from $40 and keeps a Buy rating on the shares. The company’s Q3 results were mixed, with a slight revenue miss but a margin beat, accompanied by a light Q4 revenue guide but a better outlook for margins, the analyst tells investors in a research note. The softer revenue in the quarter and lighter FY25 outlook reflects fewer implementations going live during the period, the firm added.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALKT:
- Alkami price target lowered to $34 from $41 at Lake Street
- Alkami price target lowered to $38 from $40 at JPMorgan
- Alkami Technology: Buy Rating Affirmed Amid Strong Fundamentals and Attractive Valuation
- Alkami price target lowered to $40 from $46 at Citizens JMP
- Alkami price target lowered to $25 from $30 at Barclays